Patients should attend scheduled follow-up appointments for monitoring of weight trends, metabolic parameters, and potential adverse effects
A single week of low energy doesn't show much, but three weeks in a row suggest something worth looking into
A doctor may consider the following factors: your medical history your health concerns what other medications youre taking They can also provide more information about insurance coverage and how much you can expect to pay for your prescription
Jrgensen sold 180,000 shares in 2024, likely for diversification or tax, but still ended the year with more shares than he started
TRIUMPH-3: Weight management in people with cardiovascular disease Additional TRIUMPH Trials: Type 2 diabetes management Chronic low back pain Metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH/NAFLD) Cardiovascular and renal outcomes The TRIUMPH program has enrolled more than 5,800 participants total, making it one of the largest Phase 3 programs for an obesity medication in history
Whilst these findings were encouraging, the study was relatively small and designed primarily to assess safety and feasibility rather than definitive efficacy